Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
627 gün önce
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
893 gün önce
Bay Street Headed For Positive Start
Firm commodity prices and steady global stocks amid optimism about trade deals point to a positive start for the Canadian market on Friday. Canadian jobs data for the month of April, and corporate earnings updates are also set to make an impact.
RTTNews
|
55 dakika önce
FTSE Up Nearly 0.5% On Easing Tariff Concerns
U.K. stocks are up on Friday, supported by some strong earnings updates, and continued optimism about trade deals.
U.S. President Donald Trump said on Thursday that the meetings with China on trade and economic issues could be "very substantive" and lead to tariff reductions.
RTTNews
|
2s 36 dakika önce
CAC 40 Up 0.75% On Easing Trade Tensions
French stocks are exhibiting strength on Friday, buoyed by news about the U.S. and U.K. agreeing on a trade deal, and the upcoming U.S. - China trade talks this weekend.
RTTNews
|
3s 12 dakika önce
Sensex, Nifty Extend Losses As Operation Sindoor Continues
Indian shares fell sharply on Friday to extend losses from the previous session after the Indian Army said it had countered the Pakistani attack on Indian cities late last night, fueling concerns of further escalation between the two nuclear-armed nations.
RTTNews
|
3s 19 dakika önce
DAX Moderately Higher On Trade Deal Hopes; Commerzbank Rises On Strong Results
German stocks are moderately higher on Friday, and the benchmark DAX has hit a new all-time high, with investors continuing to cheer the news about U.S.-UK trade agreement, and digesting corporate earnings announcements.
RTTNews
|
3s 30 dakika önce
Yamaha Recalls 34K Power Adaptors For Pianos, Workstations
Yamaha Corp. of America, affiliated to Japan's Yamaha Corp., is recalling about 37,400 units of power adaptors for digital pianos and music workstations citing risk of burn and fire, according to the U.S. Consumer Product Safety Commission. The recall involves Yamaha-brand AC adaptors with model number PA-300C that were sold with Yamaha-brand arranger workstations, digital pianos...
RTTNews
|
4s 11 dakika önce
